Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) — Stock Score Summary

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) has a MoatMap StockRank of 71/100 based on Quality (77/100), Value (49/100), and Momentum (29/100) factor scores. The current signal is BUY. Shanghai Xiao Fang Pharma is a domestic Chinese pharmaceutical manufacturer focused on topical formulations. It lacks the advanced biologics capabilities and global CDMO scale required to ride the CDMO pricing power cycle.

Shanghai Xiao Fang Pharmaceutical Co., Ltd. manufactures and distributes over-the-counter (OTC) dermatological drugs, external preparations, and generic pharmaceuticals. The company is well-known for its skin-care ointments and traditional external remedies, maintaining a stable market share in China's retail pharmacy channel. Its competitive moat is established through trusted consumer brands, low-cost manufacturing capabilities, and a highly stable, nationwide pharmacy distribution network.

Key Financial Metrics

Price$3.25
Market Cap$556M
P/E (TTM)17.88
Price/Book3.16
Return on Equity16.7%
Return on Invested Capital22.1%
Debt/Equity0.67
Gross Margin63.8%
Operating Margin44.8%
Revenue Growth12.9%
Dividend Yield9.8%
Free Cash Flow$-1M

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Xiao Fang Pharmaceutical Co.,Ltd.’s (603207.SS) StockRank?
MoatMap’s StockRank for Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) is 71/100, with a Buy signal. It is a composite of Quality (77), Value (49), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Xiao Fang Pharmaceutical Co.,Ltd. have an economic moat?
Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) has a Quality factor score of 77/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Xiao Fang Pharmaceutical Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) is Buy, based on a StockRank of 71/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Xiao Fang Pharmaceutical Co.,Ltd. in?
Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (603207.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks603207.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock